Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in...
Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies...
Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without...
Latest US household survey findings reveal that the Covid-19 crisis caused a sharp reduction in Americans’ confidence in institutions—whether or not they...
The House Judiciary Committee’s antitrust report was a missed opportunity. The 450-page report focused solely on digital markets. But what about antitrust...
Corruption, lobbying, corporate malfeasance, and frauds: a weekly unconventional selection of must-read articles by investigative journalist Bethany McLean.
Saving lives is the priority. Doing so depends on a delicate balance between health, economic, and social variables. But, above all, it depends on a population that trusts that these measures seek the common good, not the interest of a few.